A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

NCT04671771 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

End Stage Renal Disease (ESRD)
Kidney Failure
Chronic Renal Disease
Hemodialysis

Interventions

DEVICE: InnAVasc Arteriovenous Graft (IG) surgical implant

Sponsor

W.L.Gore & Associates